These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 22705252)

  • 1. Longitudinal multistage model for lung cancer incidence, mortality, and CT detected indolent and aggressive cancers.
    Hazelton WD; Goodman G; Rom WN; Tockman M; Thornquist M; Moolgavkar S; Weissfeld JL; Feng Z
    Math Biosci; 2012 Nov; 240(1):20-34. PubMed ID: 22705252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for early lung cancer with low-dose spiral computed tomography: results of annual follow-up examinations in asymptomatic smokers.
    Diederich S; Thomas M; Semik M; Lenzen H; Roos N; Weber A; Heindel W; Wormanns D
    Eur Radiol; 2004 Apr; 14(4):691-702. PubMed ID: 14727146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indolent, Potentially Inconsequential Lung Cancers in the Pittsburgh Lung Screening Study.
    Thalanayar PM; Altintas N; Weissfeld JL; Fuhrman CR; Wilson DO
    Ann Am Thorac Soc; 2015 Aug; 12(8):1193-6. PubMed ID: 26107281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in Patient Outcomes of Prevalence, Interval, and Screen-Detected Lung Cancers in the CT Arm of the National Lung Screening Trial.
    Schabath MB; Massion PP; Thompson ZJ; Eschrich SA; Balagurunathan Y; Goldof D; Aberle DR; Gillies RJ
    PLoS One; 2016; 11(8):e0159880. PubMed ID: 27509046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CT scan screening for lung cancer: risk factors for nodules and malignancy in a high-risk urban cohort.
    Greenberg AK; Lu F; Goldberg JD; Eylers E; Tsay JC; Yie TA; Naidich D; McGuinness G; Pass H; Tchou-Wong KM; Addrizzo-Harris D; Chachoua A; Crawford B; Rom WN
    PLoS One; 2012; 7(7):e39403. PubMed ID: 22768300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Beta-Carotene and Retinol Efficacy Trial: incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplements.
    Goodman GE; Thornquist MD; Balmes J; Cullen MR; Meyskens FL; Omenn GS; Valanis B; Williams JH
    J Natl Cancer Inst; 2004 Dec; 96(23):1743-50. PubMed ID: 15572756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender-specific outcomes of low-dose computed tomography screening for lung cancer detection: A retrospective study in Chinese never-smoker population.
    Wang H; Xie J; Chen Y; Jin J; Zhang M; Tung T; Xu Y
    Cancer Med; 2024 Sep; 13(18):e70184. PubMed ID: 39342623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exposure to low dose computed tomography for lung cancer screening and risk of cancer: secondary analysis of trial data and risk-benefit analysis.
    Rampinelli C; De Marco P; Origgi D; Maisonneuve P; Casiraghi M; Veronesi G; Spaggiari L; Bellomi M
    BMJ; 2017 Feb; 356():j347. PubMed ID: 28179230
    [No Abstract]   [Full Text] [Related]  

  • 9. CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT.
    Saghir Z; Dirksen A; Ashraf H; Bach KS; Brodersen J; Clementsen PF; Døssing M; Hansen H; Kofoed KF; Larsen KR; Mortensen J; Rasmussen JF; Seersholm N; Skov BG; Thorsen H; Tønnesen P; Pedersen JH
    Thorax; 2012 Apr; 67(4):296-301. PubMed ID: 22286927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study.
    Tammemagi MC; Schmidt H; Martel S; McWilliams A; Goffin JR; Johnston MR; Nicholas G; Tremblay A; Bhatia R; Liu G; Soghrati K; Yasufuku K; Hwang DM; Laberge F; Gingras M; Pasian S; Couture C; Mayo JR; Nasute Fauerbach PV; Atkar-Khattra S; Peacock SJ; Cressman S; Ionescu D; English JC; Finley RJ; Yee J; Puksa S; Stewart L; Tsai S; Haider E; Boylan C; Cutz JC; Manos D; Xu Z; Goss GD; Seely JM; Amjadi K; Sekhon HS; Burrowes P; MacEachern P; Urbanski S; Sin DD; Tan WC; Leighl NB; Shepherd FA; Evans WK; Tsao MS; Lam S;
    Lancet Oncol; 2017 Nov; 18(11):1523-1531. PubMed ID: 29055736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung cancer screening with low-dose computed tomography: Experiences from a tertiary hospital in Taiwan.
    Chen CY; Chen CH; Shen TC; Cheng WC; Hsu CN; Liao CH; Chen CY; Hsia TC; Liao WC; Tu CY; Shih CM; Hsu WH
    J Formos Med Assoc; 2016 Mar; 115(3):163-70. PubMed ID: 26714425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small median tumor diameter at cure threshold (<20 mm) among aggressive non-small cell lung cancers in male smokers predicts both chest X-ray and CT screening outcomes in a novel simulation framework.
    Goldwasser DL; Kimmel M
    Int J Cancer; 2013 Jan; 132(1):189-97. PubMed ID: 22510979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting.
    Manser R; Dalton A; Carter R; Byrnes G; Elwood M; Campbell DA
    Lung Cancer; 2005 May; 48(2):171-85. PubMed ID: 15829317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial.
    Walter JE; Heuvelmans MA; de Jong PA; Vliegenthart R; van Ooijen PMA; Peters RB; Ten Haaf K; Yousaf-Khan U; van der Aalst CM; de Bock GH; Mali W; Groen HJM; de Koning HJ; Oudkerk M
    Lancet Oncol; 2016 Jul; 17(7):907-916. PubMed ID: 27283862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force.
    de Koning HJ; Meza R; Plevritis SK; ten Haaf K; Munshi VN; Jeon J; Erdogan SA; Kong CY; Han SS; van Rosmalen J; Choi SE; Pinsky PF; Berrington de Gonzalez A; Berg CD; Black WC; Tammemägi MC; Hazelton WD; Feuer EJ; McMahon PM
    Ann Intern Med; 2014 Mar; 160(5):311-20. PubMed ID: 24379002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung cancer screening with spiral CT: baseline results of the randomized DANTE trial.
    Infante M; Lutman FR; Cavuto S; Brambilla G; Chiesa G; Passera E; Angeli E; Chiarenza M; Aranzulla G; Cariboni U; Alloisio M; Incarbone M; Testori A; Destro A; Cappuzzo F; Roncalli M; Santoro A; Ravasi G;
    Lung Cancer; 2008 Mar; 59(3):355-63. PubMed ID: 17936405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of Risk Factor-Based Guidelines and Model-Based Chest CT Lung Cancer Screening in World Trade Center-Exposed Fire Department Rescue/Recovery Workers.
    Cleven KL; Vaeth B; Zeig-Owens R; Colbeth HL; Jaber N; Schwartz T; Weiden MD; Markowitz SB; Silvestri GA; Prezant DJ
    Chest; 2021 May; 159(5):2060-2071. PubMed ID: 33279511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality outcomes of low-dose computed tomography screening for lung cancer in urban China: a decision analysis and implications for practice.
    Wang Z; Han W; Zhang W; Xue F; Wang Y; Hu Y; Wang L; Zhou C; Huang Y; Zhao S; Song W; Sui X; Shi R; Jiang J
    Chin J Cancer; 2017 Jul; 36(1):57. PubMed ID: 28709441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results.
    Pastorino U; Bellomi M; Landoni C; De Fiori E; Arnaldi P; Picchio M; Pelosi G; Boyle P; Fazio F
    Lancet; 2003 Aug; 362(9384):593-7. PubMed ID: 12944057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of lung-cancer mortality reduction from CT Screening.
    Henschke CI; Boffetta P; Gorlova O; Yip R; Delancey JO; Foy M
    Lung Cancer; 2011 Mar; 71(3):328-32. PubMed ID: 21168236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.